SMART-3RP Group Intervention for Stress, Psychological

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Massachusetts General Hospital, Boston, MA
Stress, Psychological+2 More
SMART-3RP Group Intervention - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance resilience and flourishing among residents in continuing care retirement communities. The investigators hypothesize that participants in the SMART-3RP group will report greater increases in resilience and flourishing relative to participants in the control group.

Eligible Conditions

  • Stress, Psychological
  • Life Stress, Psychological Resilience
  • Quality of Life (QOL)

Treatment Effectiveness

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: Up to 12 weeks

Up to 12 weeks
Community well-being: Community Well Being Survey (CWB)
Coping self-efficacy: Measure of Current Status - Part A (MOCS-A)
Flourishing: Flourishing Measure (FM)
Physical symptoms: Condensed Memorial Symptom Assessment Scale (CMSAS)
Positive affect: Positive and Negative Affect Schedule - Positive Subscale (PANAS-POS)
Psychological distress: Patient Health Questionnaire 4 (PHQ4)
Resilience: Current Experiences Scale (CES)
Social isolation: Patient-Reported Outcomes Measurement Information System - Social Isolation (PROMIS-SI)

Trial Safety

Trial Design

2 Treatment Groups

Waitlist Control Group Intervention
1 of 2
SMART-3RP Group Intervention
1 of 2
Active Control
Experimental Treatment

360 Total Participants · 2 Treatment Groups

Primary Treatment: SMART-3RP Group Intervention · No Placebo Group · N/A

SMART-3RP Group Intervention
Behavioral
Experimental Group · 1 Intervention: SMART-3RP Group Intervention · Intervention Types: Behavioral
Waitlist Control Group Intervention
Behavioral
ActiveComparator Group · 1 Intervention: SMART-3RP Group Intervention · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12 weeks

Trial Background

Prof. Lara Traeger, Assistant Professor
Principal Investigator
Massachusetts General Hospital
Closest Location: Massachusetts General Hospital · Boston, MA
Photo of Massachusetts General Hospital  1Photo of Massachusetts General Hospital  2Photo of Massachusetts General Hospital  3
1993First Recorded Clinical Trial
5 TrialsResearching Stress, Psychological
2425 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References